← Eichor
Condition: Child Pugh A Hepatocellular Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Child Pugh A Hepatocellular Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves T
Phase 1 · 11 location(s) · AbbVie · NCT06487559Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Phase 3 · 32 location(s) · Can-Fite BioPharma · NCT05201404A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer
Phase 2/Phase 3 · 2 location(s) · Inova Health Care Services · NCT06007846Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellu
Phase 2 · 14 location(s) · CatalYm GmbH · NCT07219459
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.